Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K190466
    Manufacturer
    Date Cleared
    2019-09-26

    (212 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. Tested for use with chemotherapy drugs and Fentanyl Citrate.

    Device Description

    Powder-Free Nittle Examination Glove with pH conting, Black-Gray and White-Black Colors, Tested for Use with Chemotherapy Drugs and Fentanyl Citrate

    AI/ML Overview

    This looks like a 510(k) clearance letter for medical gloves, and a table showing breakthrough times for chemotherapy drugs and fentanyl citrate. This document does not describe:

    • Acceptance Criteria for a Device: This document lists breakthrough times for certain chemicals with different glove types, which are performance data points, not acceptance criteria for an AI/ML medical device. Acceptance criteria for an AI/ML device would typically involve metrics like sensitivity, specificity, AUC, F1-score, or accuracy targets.
    • A Study Proving the Device Meets Acceptance Criteria for an AI Device: This document reports results of chemical permeation tests for gloves, not a study evaluating an AI algorithm's performance. There is no mention of AI, machine learning, algorithms, or any type of "model" in this text.

    Therefore, because the provided text is about medical gloves and their chemical resistance, and not an AI/ML medical device, I cannot fulfill your request for information related to:

    1. A table of acceptance criteria and reported device performance (for an AI/ML device).
    2. Sample size used for the test set and data provenance.
    3. Number of experts for ground truth and their qualifications.
    4. Adjudication method.
    5. MRMC comparative effectiveness study.
    6. Standalone performance.
    7. Type of ground truth used.
    8. Sample size for the training set.
    9. How ground truth for the training set was established.

    Please provide a document related to an AI/ML medical device's performance study and its acceptance criteria if you would like me to answer those specific questions.

    Ask a Question

    Ask a specific question about this device

    K Number
    K173766
    Manufacturer
    Date Cleared
    2018-07-08

    (209 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with chemotheraov drues as per ASTM D6978-05 (Reapproved 2013) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. This device is single use only.

    Device Description

    Powder-Free Nitrile Examination Glove with pH coating, Black-Gray Color, Tested for Use with Chemotherapy Drugs

    AI/ML Overview

    This document describes the acceptance criteria and the study results for the "Powder-Free Nitrile Examination Glove with pH coating, Black-Gray Color, Tested for Use with Chemotherapy Drugs".

    Here's the breakdown of the requested information:

    1. A table of acceptance criteria and the reported device performance

    The acceptance criteria for gloves used with chemotherapy drugs are typically based on the "breakthrough detection time" of various chemotherapy drugs as per ASTM D6978-05. While the document doesn't explicitly state a minimum acceptance time for all drugs (other than the general implication that a longer breakthrough time is better), the reported performance indicates that breakthrough times greater than 240 minutes are considered acceptable for most. However, two drugs showed significantly shorter breakthrough times, which the manufacturer highlights with a warning.

    Chemotherapy Drug and ConcentrationBreakthrough Detection Time in Minutes (Acceptance Criteria Implicitly >240 min for safe use)Reported Device Performance (Breakthrough Detection Time in Minutes)
    1. Carmustine (BCNU), 3.3mg/mlNot explicitly defined, but 240>240
    3. Cyclophosphamide (Cytoxan), 20mg/ml>240>240
    4. Dacarbazine (DTIC) 10mg/ml>240>240
    5. Doxorubicin Hydrochloride, 2.0 mg/ml>240>240
    6. Etoposide (Toposar), 20mg/ml>240>240
    7. Fluorouracil 50mg/ml>240>240
    8. Paclitaxel (Taxol), 6.0mg/ml>240>240
    9. Thiotepa, 10mg/mlNot explicitly defined, but
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1